Misha  Petkevich net worth and biography

Misha Petkevich Biography and Net Worth

Director of CohBar
Mr. Petkevich has more than 30 years of financial and investment experience in biotechnology and investment banking. Since 2015, Mr. Petkevich has been the Chief Investment Officer of V2M Capital, an investment firm funding life science companies. He currently serves on the board of directors of HingeBio, Inc., a biotechnology company developing bispecific and multispecific antibodies.  In 2005, he co-founded BladeRock Capital, LLC, an investment firm specializing in life science companies. Prior to founding BladeRock Capital, Mr. Petkevich founded The Petkevich Group, a biotechnology advisory firm, where he was Chairman and Chief Executive Officer from 1998 to 2005. Between 1989 and 1997, Mr. Petkevich served as Managing Director, as well as Head of Healthcare and Investment Banking at Robertson Stephens & Co.  Mr. Petkevich began his career at Hambrecht & Quist, an investment bank, where he served as a Principal, Head of Healthcare Banking and as a biotechnology analyst covering Genentech, Chiron and others. Mr. Petkevich received his bachelor’s degree from Harvard University and his DPhil from the University of Oxford. 

How do I contact Misha Petkevich?

The corporate mailing address for Mr. Petkevich and other CohBar executives is 1455 Adams Drive Suite 2050, Menlo Park CA, 94025. CohBar can also be reached via phone at (650) 446-7888 and via email at [email protected]. Learn More on Misha Petkevich's contact information.

Has Misha Petkevich been buying or selling shares of CohBar?

Misha Petkevich has not been actively trading shares of CohBar within the last three months. Most recently, on Thursday, October 28th, Misha Petkevich bought 167,000 shares of CohBar stock. The stock was acquired at an average cost of $0.58 per share, with a total value of $96,860.00. Learn More on Misha Petkevich's trading history.

Who are CohBar's active insiders?

CohBar's insider roster includes Kenneth Cundy (Insider), Misha Petkevich (Director), and Joseph Sarret (CEO). Learn More on CohBar's active insiders.

Misha Petkevich Insider Trading History at CohBar

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/28/2021Buy167,000$0.58$96,860.00View SEC Filing Icon  
9/2/2020Buy6,000$1.00$6,000.00View SEC Filing Icon  
See Full Table

Misha Petkevich Buying and Selling Activity at CohBar

This chart shows Misha Petkevich's buying and selling at CohBar by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

CohBar Company Overview

CohBar logo
CohBar, Inc., a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases. It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the treatment of nonalcoholic steatohepatitis and obesity; and CB5138 Analogs, which is in preclinical study to treat idiopathic pulmonary fibrosis and other fibrotic diseases. CohBar, Inc. was incorporated in 2007 and is based in Menlo Park, California.
Read More

Today's Range

Now: $0.88
Low: $0.88
High: $0.88

50 Day Range

MA: $0.82
Low: $0.75
High: $1.01

2 Week Range

Now: $0.88
Low: $0.58
High: $6.90

Volume

516 shs

Average Volume

3,565 shs

Market Capitalization

$2.56 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.52